AR115475A2 - Método para la síntesis de (1s,2r)-milnaciprán - Google Patents

Método para la síntesis de (1s,2r)-milnaciprán

Info

Publication number
AR115475A2
AR115475A2 ARP190101513A ARP190101513A AR115475A2 AR 115475 A2 AR115475 A2 AR 115475A2 AR P190101513 A ARP190101513 A AR P190101513A AR P190101513 A ARP190101513 A AR P190101513A AR 115475 A2 AR115475 A2 AR 115475A2
Authority
AR
Argentina
Prior art keywords
formula
previous step
reaction
amide
milnacipran
Prior art date
Application number
ARP190101513A
Other languages
English (en)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR115475A2 publication Critical patent/AR115475A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicación 1: Un método para sintetizar una sal de adición de ácido farmacéutica aceptable de (1S,2R)-milnaciprán de la fórmula (1), que comprende los siguientes pasos sucesivos: (a) reacción de fenilacetonitrilo y de (R)-epiclorhidrina en presencia de una base que contiene un metal alcalino, seguida por un tratamiento básico, y luego por un tratamiento ácido para obtener la lactona de la fórmula (2); (b) reacción de la lactona de fórmula (2) obtenida en el paso (a) previo con MNEt₂, en donde M representa un metal alcalino, o con NHEt₂ en presencia de un complejo de ácido de Lewis-amina en donde la amina es seleccionada entre dietilamina, trietilamina, diisopropiletilamina, N,N-dietilanilina, N,N-dimetilbencilamina, N-metilpiperidina, N-metilmorfolina, N,N’-dimetilpiperazina y hexametilentetramina, para obtener el amida-alcohol de la fórmula (3); (c) reacción del amida-alcohol de fórmula (3) obtenido en el paso (b) previo con cloruro de tionilo para obtener la amida clorada de la fórmula (4); (d) reacción de la amida clorada de fórmula (4) obtenida en el paso (c) previo con una sal de ftalimida, tal como la sal de potasio, para obtener el derivado de ftalimida de la fórmula (5); (e) hidrólisis del grupo ftalimida del derivado de ftalimida de fórmula (5) obtenido en el paso (d) previo, para obtener (1S,2R)-milnaciprán; y (f) salificación del (1S,2R)-milnaciprán obtenido en el paso (e) previo en un sistema adecuado de solventes, en presencia de un ácido farmacéuticamente aceptable, caracterizado porque los pasos (a) a (e) son llevados a cabo en un medio de reacción que comprende un mismo y único solvente que es tolueno.
ARP190101513A 2009-01-29 2019-06-04 Método para la síntesis de (1s,2r)-milnaciprán AR115475A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0950552A FR2941454B1 (fr) 2009-01-29 2009-01-29 Proced de synthese du (1s,2r)-milnacipran

Publications (1)

Publication Number Publication Date
AR115475A2 true AR115475A2 (es) 2021-01-20

Family

ID=40920574

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP100100245A AR077526A1 (es) 2009-01-29 2010-01-29 Metodo para la sintesis de (1s,2r)- milnacipran
ARP190101513A AR115475A2 (es) 2009-01-29 2019-06-04 Método para la síntesis de (1s,2r)-milnaciprán

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP100100245A AR077526A1 (es) 2009-01-29 2010-01-29 Metodo para la sintesis de (1s,2r)- milnacipran

Country Status (23)

Country Link
US (1) US8604241B2 (es)
EP (1) EP2391599B1 (es)
JP (1) JP5646509B2 (es)
KR (1) KR101719011B1 (es)
CN (2) CN102300840A (es)
AR (2) AR077526A1 (es)
AU (1) AU2010209686B2 (es)
BR (1) BRPI1007404B8 (es)
CA (1) CA2750488C (es)
ES (1) ES2472695T3 (es)
FR (1) FR2941454B1 (es)
GE (1) GEP20135903B (es)
IL (1) IL214241A (es)
MA (1) MA33025B1 (es)
MX (1) MX2011007846A (es)
NZ (1) NZ594291A (es)
PL (1) PL2391599T3 (es)
RU (1) RU2521342C2 (es)
TN (1) TN2011000363A1 (es)
TW (1) TWI455911B (es)
UA (1) UA104884C2 (es)
WO (1) WO2010086394A1 (es)
ZA (1) ZA201105414B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944011B1 (fr) * 2009-04-03 2011-05-20 Pf Medicament Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments.
WO2011158249A1 (en) * 2010-06-16 2011-12-22 Glenmark Generics Limited Process for preparation of milnacipran intermediate and its use in preparation of pure milnacipran
WO2012046247A2 (en) * 2010-10-06 2012-04-12 Msn Laboratories Limited Process for the preparation of (±m1r(s), 2srr)l-2-(aminomethyl)-n,n-diethyl-l-phenylcyclopropane carboxamide hydrochloride
ES2613709T3 (es) * 2011-01-24 2017-05-25 Bayer Intellectual Property Gmbh Procedimiento para la preparación de 2,2-difluoroetilamina a partir de 2,2-difluoro-1-cloroetano
US9416109B2 (en) * 2012-02-17 2016-08-16 Eisai R&D Management Co., Ltd. Methods and compounds useful in the synthesis of orexin-2 receptor antagonists
WO2014009767A1 (en) 2012-07-07 2014-01-16 Micro Labs Limited An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts
EP2805936A1 (en) 2013-05-20 2014-11-26 Cosma S.p.A. Process for preparing levomilnacipran HCL
WO2014203277A2 (en) * 2013-06-19 2014-12-24 Msn Laboratories Private Limited Process for the preparation of (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanearboxamide hydrochloride
CN103694162B (zh) * 2014-01-03 2015-09-02 上海现代制药股份有限公司 (1s,2r)-1-苯基2-(酞酰亚胺)甲基-n,n-二乙基-环丙甲酰胺的制备方法
CN104058992A (zh) * 2014-06-13 2014-09-24 上海现代制药股份有限公司 左旋米那普仑盐酸盐的晶型
JP2017533892A (ja) * 2014-10-03 2017-11-16 ピュラック バイオケム ビー. ブイ. N,n−ジアルキルラクトアミドの製造法
ES2746081T3 (es) 2014-11-04 2020-03-04 Quim Sintetica S A Procedimiento para la preparación de (1S,2R)-milnaciprán
CN106083638A (zh) * 2016-07-07 2016-11-09 佛山市隆信医药科技有限公司 一种盐酸左旋米那普仑的制备方法
CN111175387B (zh) * 2018-11-13 2022-06-07 成都康弘药业集团股份有限公司 一种米那普仑异构体的检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508035A1 (fr) 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2581059B1 (fr) 1985-04-25 1988-04-22 Pf Medicament Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z)
FR2640972B1 (es) * 1988-12-28 1991-04-19 Pf Medicament
JPH0834765A (ja) * 1994-02-22 1996-02-06 Asahi Chem Ind Co Ltd アミノアルキルシクロプロパン誘導体
WO1995022521A1 (fr) 1994-02-22 1995-08-24 Asahi Kasei Kogyo Kabushiki Kaisha Derive d'aminoalkylcyclopropane
WO2005118564A2 (en) 2004-06-01 2005-12-15 Collegium Pharmaceutical, Inc. Methods for the synthesis of milnacipran and congeners thereof
JP4712320B2 (ja) 2004-06-16 2011-06-29 住友化学株式会社 2−オキソ−1−フェニル−3−オキサビシクロ[3.1.0]ヘキサンの製造方法
JP4418717B2 (ja) * 2004-06-24 2010-02-24 住友化学株式会社 (z)−1−フェニル−1−ジエチルアミノカルボニル−2−アミノメチルシクロプロパン塩酸塩の製造方法
CN100579954C (zh) 2004-06-25 2010-01-13 住友化学株式会社 (z)-1-苯基-1-二乙氨基羰基-2-羟甲基环丙烷的制造方法
JP4828863B2 (ja) 2005-01-28 2011-11-30 住友化学株式会社 (z)−1−フェニル−1−(n,n−ジエチルアミノカルボニル)−2−フタルイミドメチルシクロプロパンの製造方法
KR100772244B1 (ko) * 2005-07-20 2007-11-01 안국약품 주식회사 밀나시프란염산염의 제조방법
KR20140068261A (ko) 2009-12-04 2014-06-05 인터디지탈 패튼 홀딩스, 인크 하이브리드 네트워크에서 통합 게이트웨이에 대한 확장형 로컬 ip 액세스

Also Published As

Publication number Publication date
TWI455911B (zh) 2014-10-11
FR2941454B1 (fr) 2011-04-01
KR101719011B1 (ko) 2017-03-22
RU2521342C2 (ru) 2014-06-27
GEP20135903B (en) 2013-08-12
MA33025B1 (fr) 2012-02-01
JP2012516307A (ja) 2012-07-19
IL214241A0 (en) 2011-09-27
CN110204455A (zh) 2019-09-06
IL214241A (en) 2015-03-31
CN102300840A (zh) 2011-12-28
CA2750488C (en) 2016-12-13
PL2391599T3 (pl) 2014-09-30
BRPI1007404B8 (pt) 2021-05-25
AU2010209686B2 (en) 2014-06-05
MX2011007846A (es) 2011-12-14
TW201031623A (en) 2010-09-01
BRPI1007404B1 (pt) 2020-10-13
UA104884C2 (uk) 2014-03-25
EP2391599A1 (en) 2011-12-07
WO2010086394A1 (en) 2010-08-05
US8604241B2 (en) 2013-12-10
NZ594291A (en) 2012-11-30
AR077526A1 (es) 2011-09-07
CA2750488A1 (en) 2010-08-05
ES2472695T3 (es) 2014-07-02
JP5646509B2 (ja) 2014-12-24
AU2010209686A1 (en) 2011-08-18
KR20110108409A (ko) 2011-10-05
ZA201105414B (en) 2012-03-28
EP2391599B1 (en) 2014-04-09
TN2011000363A1 (en) 2013-03-27
BRPI1007404A2 (pt) 2016-02-16
US20110295036A1 (en) 2011-12-01
RU2011135326A (ru) 2013-03-10
FR2941454A1 (fr) 2010-07-30

Similar Documents

Publication Publication Date Title
AR115475A2 (es) Método para la síntesis de (1s,2r)-milnaciprán
JP5186722B2 (ja) スルフリルフルオリドを用いるフッ素化反応
JP4940790B2 (ja) 脱ヒドロキシフッ素化剤
Hodgkinson et al. Robust routes for the synthesis of N-acylated-L-homoserine lactone (AHL) quorum sensing molecules with high levels of enantiomeric purity
PE20100487A1 (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
RU2015142826A (ru) Способ получения натриевой соли (2s, 5r)-2-карбоксамидо-7-оксо-6-сульфоокси-1, 6-диаза-бицикло[3.2.1]октана
RU2018126365A (ru) Способ расщепления амидных связей
EA201290872A1 (ru) Способ получения бензоксаборолов
RU2018132264A (ru) Промежуточные продукты в синтезе эрибулина и соответствующие способы синтеза
CO6290754A2 (es) Método para producir bicarbonato de arginina
AR107494A1 (es) Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y “azd9291 anilina” o una sal de la misma
PE20090956A1 (es) PROCESO PARA LA OBTENCION DE DERIVADOS DE PIRIDO [2,1-a] - ISOQUINOLINA
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
Neelarapu et al. A one-pot selective synthesis of N-Boc protected secondary amines: tandem direct reductive amination/N-Boc protection
NO20082271L (no) Framgangsmate for framstilling av ioheksol
JP6377676B2 (ja) 新規なヒドロキサム酸誘導体の製造方法
CN103709194B (zh) 光学活性的羟基保护的脂肪族磷酸酯的制备方法
US11708341B2 (en) Synthesis of (S)-2-amino-4-methyl-((R)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
Lee et al. Ring-opening of cis-3-Substituted-2-vinylaziridines with Heteroatom Nucleophiles
PE20140580A1 (es) Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas
RU2010114505A (ru) Способ получения 2,2'-дихлордиэтилформаля
JP6426015B2 (ja) 光学活性含フッ素アミン化合物及びその製造方法
US9212158B2 (en) Method for preparing a fatty acid derivative
RU2010115296A (ru) Пфон-1
Jacobo et al. An efficient preparation of stereospecific β-hydroxy nitriles